All American Urological Association members can thrive under 'big tent,' says AUA president
The AUA is challenged with staying fair and relevant to all urologists under the "big tent," even though academic-employed urologists, non-academic-employed urologists, those in private practice, and those in large group practices may have different priorities and problems.
The AUA is challenged with staying fair and relevant to all urologists under the "big tent," even though academic-employed urologists, non-academic-employed urologists, those in private practice, and those in large group practices may have different priorities and problems. That is a key message from Dennis A. Pessis, MD, who discusses his goals as AUA president in 2012-'13 in this exclusive interview. Dr. Pessis is professor of urology at Rush University Medical Center in Chicago. He was interviewed by J. Brantley Thrasher, MD, professor and chair of urology at the University of Kansas Medical Center, Kansas City.
Q What are the primary issues and concerns that face the AUA and its membership over the next year as you see it?
It's important to realize that we also have a lot of common problems that we can work on together. If we understand the common problems that we have to solve, it becomes easier to prioritize those issues that we may not have in common.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
